Across TCGA pan-cancer cohorts, CLIC4P3 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of CLIC4P3’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where CLIC4P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CLIC4P3 is over-expressed in tumor, although a few such as STAD and UCEC show the opposite, repressed pattern.
HNSC, COAD, and STAD are the cancer types where CLIC4P3 tumor–normal differential expression is most reproducible.